Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$103.53 USD

103.53
693,737

+1.62 (1.59%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $103.58 +0.05 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (58 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Swayta Shah headshot

5 Top Stocks With Impressive Sales Growth to Buy Right Away

by Swayta Shah

Sales growth is important for the survival of any business. Let's check Encompass Health (EHC), Celanese (CE), salesforce.com (CRM), Ovintiv (OVV) & Expeditors International (EXPD) that are likely to witness solid top-line growth.

EHC or AMED: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

EHC vs. AMED: Which Stock Is the Better Value Option?

Is a Surprise Coming for Encompass Health (EHC) This Earnings Season?

by Zacks Equity Research

Encompass Health (EHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

What's in the Cards for Universal Health's (UHS) Q2 Earnings?

by Zacks Equity Research

Universal Health's (UHS) second-quarter results are likely to reflect improving revenues stemming from growing patient admissions, partly offset by high costs.

Encompass Health (EHC) Continues to Boost Presence in Florida

by Zacks Equity Research

Encompass Health (EHC) plans to construct an inpatient rehabilitation hospital in Florida in a bid to offer improved health outcomes across the state.

    Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    EHC or AMED: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    EHC vs. AMED: Which Stock Is the Better Value Option?

    Encompass Health (EHC) to Expand Inpatient Rehabilitation Unit

    by Zacks Equity Research

    Encompass Health (EHC) to construct an inpatient rehabilitation hospital to capture a market with great prospects.

    HCA Healthcare (HCA) Buys 80% Stake in BHS, Boosts Network

    by Zacks Equity Research

    HCA Healthcare (HCA) completes purchase of majority stake in Brookdale's BHS, which has added around 80 care sites to the former's portfolio enabling it to offer enhanced healthcare services.

    Encompass Health (EHC), Altru Forms JV to Serve North Dakota

    by Zacks Equity Research

    Encompass Health (EHC) inks JV with Altru for sharing responsibility of operating the latter's inpatient rehabilitation hospital and offer better health outcomes across North Dakota.

    Sapna Bagaria headshot

    Forget Clover Health (COLV), Buy 3 Non-Meme Healthcare Bets Instead

    by Sapna Bagaria

    Despite being hotly traded on social-media platforms, Cover Health (CLOV) offers little investment value to long-term investors.

    Here's Why You Should Retain Stryker (SYK) Stock Right Now

    by Zacks Equity Research

    Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises a concern.

    NextGen (NXGN) Partners With Palmetto to Boost Patient Experience

    by Zacks Equity Research

    NextGen (NXGN) collaborates with Palmetto to enhance patient experience, through the latter's adoption of NextGen RCM Services.

    Here's Why You Should Hold on to Universal Health (UHS) Now

    by Zacks Equity Research

    Banking on its Acute Care and Behavioral Health platforms along with a robust capital position, Universal Health (UHS) holds potential to reap benefits for investors.

      Here's Why You Should Retain Integer Holdings (ITGR) Stock

      by Zacks Equity Research

      Integer Holdings (ITGR) continues to gain traction from portfolio management.

        The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita

        by Zacks Equity Research

        The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita

        5 Reasons That Make Encompass Health (EHC) an Attractive Bet

        by Zacks Equity Research

        Encompass Health's (EHC) optimistic business prospects make it a lucrative stock to own for strong gains.

        Save Your Portfolio From Inflation With Four Healthcare Stocks

        by Zacks Equity Research

        Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.

        Avantor, Inc. (AVTR) Hits 52-Week High, Can the Run Continue?

        by Zacks Equity Research

        Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

        Here's Why You Should Retain Change Healthcare (CHNG) Stock

        by Zacks Equity Research

        Change Healthcare (CHNG) continues to benefit from robust payment accuracy business. However, intense competition remains a woe.

        Patterson Companies' (PDCO) Unit Completes Miller Vet Buyout

        by Zacks Equity Research

        Patterson Companies' (PDCO) subsidiary completes acquisition of Miller Vet, which is likely to bolster its Animal Health's presence in the companion animal market.

        Encompass Health (EHC) Expands Inpatient Rehab Business

        by Zacks Equity Research

        Encompass Health (EHC) continues to strengthen its inpatient rehabilitation business by opening a hospital.

        Ecolab (ECL) to Aid Life Sciences Industry With New Offering

        by Zacks Equity Research

        Ecolab (ECL) unveils new virtual service offering to help the life sciences industry to address cleaning and disinfection challenges.

        Here's Why You Should Invest in Intuitive Surgical (ISRG) Now

        by Zacks Equity Research

        Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.

        DaVita's (DVA) Deal to Aid Patients in Kidney Transplantation

        by Zacks Equity Research

        DaVita (DVA) and NKF collaborate to help kidney patients seeking a living donor, thereby improving health equity in kidney transplant process.